How Is Prostate Cancer Diagnosed? Tests, Criteria & Process
Prostate Cancer diagnosis relies on Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9). Learn the full diagnostic pathway, clinical criteria, differential workup, and what to expect at your evaluation.
Updated March 27, 2026
Prostate Cancer is diagnosed using Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9) and targeted clinical evaluation. Prostate cancer is the most common cancer in men, growing in the prostate gland. Most cases are slow-growing, but aggressive forms can spread rapidly; PSA screening and biopsy are key diagnostic tools.
Clinical Context
The diagnostic process for Prostate Cancer begins with Cross-sectional imaging for mass lesion detection; biopsy for histological confirmation; staging workup before MDT treatment decision. Key investigations include Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9), Full blood count and peripheral blood film. The gold standard is: Tissue biopsy is the gold standard for all malignancies; bone marrow trephine for haematological staging. Clinical guidelines from ESMO / ASCO / NCCN / ASH / NICE Oncology define the diagnostic criteria and recommended investigation pathway.
Clinical Pathway
Prostate Cancer — Full Condition GuideCondition HubProstate Cancer — Differential DiagnosisDifferentialProstate Cancer — Treatment PathwaysTreatmentBenign Prostatic Hyperplasia (BPH) vs. Prostate Cancer — Comparisonvs.Prostate Cancer — Prognosis & OutlookPrognosisFrequently Asked Questions
How Is Prostate Cancer Diagnosed? Tests, Criteria & Process?+
Prostate Cancer is diagnosed using Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9) and targeted clinical evaluation. Prostate cancer is the most common cancer in men, growing in the prostate gland. Most cases are slow-growing, but aggressive forms can spread rapidly; PSA screening and biopsy are key diagnostic tools.
How do doctors test for prostate cancer?+
The main tests used to diagnose Prostate Cancer include Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9). Your doctor will select investigations based on your symptoms, clinical findings, and risk factors.
How long does it take to diagnose Prostate Cancer?+
The time to diagnosis varies. Some cases are identified within hours using clinical presentation and blood tests; others require weeks, repeated investigations, or specialist referral.
Can Prostate Cancer be missed on initial testing?+
Yes — Prostate Cancer can be missed if initial tests are negative or if the presentation is atypical. If clinical suspicion remains high, repeat testing or specialist referral is appropriate.
Our AI Symptom Checker analyzes your symptoms and suggests possible conditions based on clinical guidelines.
Start Free Analysis →